Century Therapeutics, Inc. IPSC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Century Therapeutics Inc. is a biotechnology company that focuses on developing innovative cell therapies for cancer treatment. The company's core mission centers around harnessing the potential of induced pluripotent stem cells (iPSCs) to create highly effective, off-the-shelf cellular therapies. By leveraging iPSCs, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees78
TickerIPSC
Statistics
Market Cap$404.3M
Revenue (TTM)$109.2M
Net Income-$9.6M
Net Margin-8.8%
EPS$-0.14
P/E-16.00
P/S3.70
P/B1.49
EV/EBITDA-3.07
ROE-42.7%
Dividend Yield—
Price$2.25
Data: Twelve Data · Revenue = mcap / P/S